1. Home
  2. NTLA vs BBSI Comparison

NTLA vs BBSI Comparison

Compare NTLA & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • BBSI
  • Stock Information
  • Founded
  • NTLA 2014
  • BBSI 1965
  • Country
  • NTLA United States
  • BBSI United States
  • Employees
  • NTLA N/A
  • BBSI N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BBSI Professional Services
  • Sector
  • NTLA Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • NTLA Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • NTLA 959.4M
  • BBSI 1.1B
  • IPO Year
  • NTLA 2016
  • BBSI 1993
  • Fundamental
  • Price
  • NTLA $9.53
  • BBSI $43.29
  • Analyst Decision
  • NTLA Buy
  • BBSI Buy
  • Analyst Count
  • NTLA 18
  • BBSI 3
  • Target Price
  • NTLA $50.53
  • BBSI $41.67
  • AVG Volume (30 Days)
  • NTLA 3.2M
  • BBSI 79.9K
  • Earning Date
  • NTLA 02-20-2025
  • BBSI 02-26-2025
  • Dividend Yield
  • NTLA N/A
  • BBSI 0.74%
  • EPS Growth
  • NTLA N/A
  • BBSI 10.06
  • EPS
  • NTLA N/A
  • BBSI 1.89
  • Revenue
  • NTLA $43,086,000.00
  • BBSI $1,116,393,000.00
  • Revenue This Year
  • NTLA $50.68
  • BBSI $8.11
  • Revenue Next Year
  • NTLA N/A
  • BBSI $7.27
  • P/E Ratio
  • NTLA N/A
  • BBSI $22.83
  • Revenue Growth
  • NTLA N/A
  • BBSI 4.87
  • 52 Week Low
  • NTLA $9.25
  • BBSI $27.06
  • 52 Week High
  • NTLA $34.87
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 36.07
  • BBSI 51.40
  • Support Level
  • NTLA $9.93
  • BBSI $42.44
  • Resistance Level
  • NTLA $10.73
  • BBSI $44.31
  • Average True Range (ATR)
  • NTLA 0.66
  • BBSI 0.89
  • MACD
  • NTLA 0.08
  • BBSI -0.07
  • Stochastic Oscillator
  • NTLA 13.12
  • BBSI 35.38

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: